SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
PFE Analysis & Videos »
PFE: Bull or Bear?
Week in Preview: Election, QE2, Unemployment and More Earnings
PFE
+28.45%
in
574 days
Filed under: Earnings Reports, Forecasts, Starbucks (SBUX), Toyota Motor Corp. (TM), Economic Data, Teva Pharm Indus ADR (TEVA), Stocks to Buy, Federal Reserve, Marathon Oil (MRO) <> It will be a busy week. Republicans are poised to gain control of the House of Representatives and gain governorships in Tuesday's mid-term elections. Also, the Federal Reserve is expected to announce another round of quantitative easing Wednesday, following the FOMC meeting. Major retailers are scheduled to report October same-store sales Thursday, while the October unemployment rate, announced on Friday, is expec...
|
Three Dividend Duds to Sell Now
PFE
-53.85%
in
699 days
Filed under: Pfizer (PFE), Stocks to Sell  Stocks paying dividends are in favor on Wall Street right now as investors look to insulate themselves from the recent market volatility. But what happens when these stocks actually end up losing you cash instead of protecting your portfolio?
If you're losing a significant amount of money as the share prices of your high yield dividend stocks dive, then it may be time to pull the trigger and sell these dividend duds. After all there are a host of income friendly stocks out there, so why should you settle for one that offsets your quarterly dividends w...
|
Deadbeat Stock #4: Pfizer (PFE)
PFE
-32.29%
in
798 days
Filed under: Pfizer (PFE), Stocks to Sell  Pfizer (PFE) was the darling of the 1990s. Well, so was Bill Clinton, and like Clinton, the company pops up now and again in the news, but none of it really matters.
Pfizer's premier product, Lipitor, comes off patent this year and will get hit by generic competition in 2011. This drug has $11 billion in sales, which will shrink to $4 billion or less, and with that could go $5 billion or so in profits. Continue reading Deadbeat Stock #4: Pfizer (PFE) <>Deadbeat Stock #4: Pfizer (PFE) originally appeared on BloggingStocks on Sun, 21 Mar 2010 09:00:00 EST. ...
|
Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth
PFE
|
|
|
+18.99%
in
846 days
<>Filed under: Hewlett-Packard (HPQ), eBay (EBAY), Pfizer (PFE), Wal-Mart (WMT), International Business Machines (IBM), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Abbott Laboratories (ABT), AFLAC Inc (AFL), Altria Group (MO), Archer-Daniels-Midland (ADM), AutoZone Inc (AZO), Bristol-Myers Squibb (BMY), Campbell Soup (CPB), Chevron Corp (CVX), Chubb Corp (CB), ConocoPhillips (COP), CVS Corp (CVS), Darden Restaurants (DRI), Goldman Sachs Group (GS), General Mills (GIS), Verizon Communications (VZ), duPont(E.I.)deNemours (DD), Kimberly-Clark (KMB), Merck and Co (MRK), Lockheed Martin (LMT)...
|
A 130 / 30 Global Pharma ETF Strategy
PFE
|
|
|
-32.13%
in
935 days
<> Investors who are bullish on the generic drug industry may consider implementing a 130 / 30 global pharma investing strategy through equal-weight (5% each) short positions for the six brand drug companies outlined below with 30% of their assets while investing 130% of assets in long positions among generic drug makers. The list of brand drug companies with significant patent expiration exposure over the next 2-3 years includes Pfizer (NYSE: PFE ), GlaxoSmithKline (NYSE: GSK ), Takeda Pharma (OTC: TKPHY.PK ), Sanofi-Aventis ( SNY ), AstraZeneca ( AZN ), and Merck ( MRK ).
...
|
FDA, Clinical Trial Calendar Updates: Weight Loss, Diabetes, and More
PFE
|
|
|
+20.76%
in
217 days
(closed on 11/04/09)
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 110 entries through 4/1/09. The FDA Calendar includes the following information: company name, ticker, decision d...
|
Big Pharma Goes Generic
PFE
|
|
|
-6.13%
in
34 days
(closed on 04/01/09)
<> <> <> <> <> <>  Sanofi-Aventis (SNY) is now the 11 th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVent...
|
A 130/30 Pharma Trade
PFE
|
|
|
+4.48%
in
6 days
(closed on 02/26/09)
By Mike Havrilla on 2/20/09 ETF Innovators The tables at my website link below include 12 U.S. listed companies from the ETF Innovators Global Generic Drug Index along with seven brand drug companies, which are ranked in descending order based on their patent expiration exposure through the end of 2011 as a percentage of total trailing 12-month revenue. <> Investors who are bullish on the generic drug industry may consider implementing a 130/30 pharma trade by shorting any/all...
|
Trading the Trials and FDA Decision Calendar
PFE
|
|
|
-16.03%
in
27 days
(closed on 02/20/09)
Trading the Trials and FDA Decision Calendar The tables at my website links below feature an updated calendar of 80 expected FDA new product decisions and 89 pending clinical trial result estimates + pending FDA re-submissions. Click here for a link to my previous FDA calendars and click here for a list of 14 extreme trades of companies with market caps below $100M and pending new drug decisions at the FDA. <> Below is a summary of the major updates on the calendar...
|
Cramer on BloggingStocks: Cramer bullish on the Dow for '09 -- Part V
PFE
-6.79%
in
199 days
(closed on 07/27/09)
Filed under: General Electric (GE), Pfizer (PFE), Wal-Mart (WMT), Exxon Mobil (XOM), AT and T (T), Target Corp. (TGT), Johnson and Johnson (JNJ), Comcast Cl'A' (CMCSA), Procter and Gamble (PG), Lowe's Cos (LOW), Verizon Communications (VZ), Merck and Co (MRK), United Technologies (UTX), DJIA, Stocks to Buy, Cramer on BloggingStocks TheStreet.com's Jim Cramer sees a stalled industrial and a winning retail play in this final portion of his 2009 predictions.
This is the...
|
Pfizer 'admits' it's in trouble
PFE
-24.28%
in
1237 days
Filed under: Bad news, Pfizer (PFE), Stocks to Sell  In a period of economic distress, owning stocks with stable cash flows is a great way to avoid the carnage found in other parts of the market. One sector traditionally known to provide consistent cash flow to investors is the pharmaceutical industry.
Patent protection on drugs provides the industry with the ability to generate revenue unencumbered by competition. Investors generally pay a premium to own a piece of that stream -- no matter what is happening in the economy. <>During the last few years, market premium for drug companies has been d...
|
People Bullish on PFE
People Bearish on PFE
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
|
|
|
|
|
tanumoy
(-48.35% risk: conservative)
|
|
|
More Resources
|
About Pfizer Inc
- Answers.com
Spring is finally here, which means it's time to break out the broom and dustpan for some spring cleaning.
"The silver lining to the market decline is that some of our favorite stocks have fallen into 'buy' territory," says 
